The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems
The implications of combining two unapproved or investigational compounds are significant
The outcome measures were documented and categorized pragmatically by merging similar outcomes into broader categories to facilitate reporting (namely, patient-reported outcomes [PROs], biomarkers and biochemical effects, cardiometabolic outcomes, health behaviors/practices, and health economics)
Therefore, I consider them an adjunct therapy to improve the underlying metabolic environment before fertility treatment, rather than a primary fertility medication
L., Schloos, J
In agreement with previous research on GLP-1 receptor agonists, GLP-1MK-801 increased the excitability of around 35% of POMC-expressing neurons 19 (POMC neurons